
Xoneact SB 250mg/125mg Injection
Marketer
Cee Bee Laboratories
Salt Composition
Ceftriaxone (250mg) + Sulbactam (125mg)
Overview Xoneact SB 250mg/125mg Injection
Combiflox, a 250mg/125mg injectable formulation, combats diverse bacterial infections. Its mechanism halts microbial proliferation, thereby controlling infection spread. Administration must be overseen by a medical professional; adherence to the prescribed schedule is crucial. Complete the entire treatment course, regardless of symptom improvement; premature cessation may compromise efficacy. Commonly reported side effects include nausea, vomiting, diarrhea, and dyspepsia. Worsening side effects necessitate immediate medical attention. Seek immediate medical assistance for allergic reactions (e.g., rash, pruritus, edema, dyspnea). Inform your physician of all current medications before commencing treatment. Pregnant or lactating individuals should consult their physician prior to use. Alcohol consumption should be avoided due to potential additive drowsiness. While generally non-impairing to driving ability, refrain from driving if drowsiness or dizziness occurs. Adequate rest, a balanced diet, and ample hydration are recommended for optimal recovery. Your doctor may order laboratory tests to monitor treatment response.
Uses of Xoneact SB 250mg/125mg Injection
Infections caused by bacteria
Major Benefits of Xoneact SB 250mg/125mg Injection:
This medication will be administered by your physician or their designated nurse; self-medication is strictly prohibited.
Common Side effects of Xoneact SB 250mg/125mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Xoneact SB 250mg/125mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Xoneact SB 250mg/125mg Injection works:
Xoneact SB Injection, containing 250mg Ceftriaxone and 125mg Sulbactam, utilizes a dual-action approach to combat bacterial infections. Ceftriaxone, a potent antibiotic, disrupts bacterial cell wall synthesis, hindering their ability to thrive. The inclusion of Sulbactam, a beta-lactamase inhibitor, counteracts bacterial defenses, thereby optimizing Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Ingestion of alcohol alongside Xoneact SB 250mg/125mg Injection poses no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Xoneact SB, containing 250mg/125mg, is typically deemed safe for use in pregnant individuals. Preclinical trials using animals have revealed minimal or no negative impacts on fetal development; despite this, data from human studies remain scarce.
Breast feedingCAUTION
The administration of Xoneact SB 250mg/125mg Injection necessitates prudence while breastfeeding. Lactation should cease until maternal treatment concludes and the medication is fully cleared from the maternal system.
DrivingUNSAFE
Administering Xoneact SB 250mg/125mg Injection could reduce attentiveness, impair vision, and induce drowsiness or dizziness. Driving is prohibited should these effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Xoneact SB 250mg/125mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
Xoneact SB 250mg/125mg Injection requires careful administration in individuals with severe hepatic impairment; dosage modification may be necessary. A physician's consultation is advised. Dosage alteration for Xoneact SB 250mg/125mg Injection is unnecessary for patients exhibiting mild to moderate liver dysfunction.
What if you forget to take Xoneact SB 250mg/125mg Injection :
Should you inadvertently omit a scheduled dose of Xoneact SB 250mg/125mg Injection, seek advice from your physician.
Facts to Know About Xoneact SB 250mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobials |
